Does DURVALUMAB Cause Haemoglobin decreased? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Haemoglobin decreased have been filed in association with DURVALUMAB (IMFINZI). This represents 0.4% of all adverse event reports for DURVALUMAB.
63
Reports of Haemoglobin decreased with DURVALUMAB
0.4%
of all DURVALUMAB reports
11
Deaths
30
Hospitalizations
How Dangerous Is Haemoglobin decreased From DURVALUMAB?
Of the 63 reports, 11 (17.5%) resulted in death, 30 (47.6%) required hospitalization, and 8 (12.7%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DURVALUMAB. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which DURVALUMAB Alternatives Have Lower Haemoglobin decreased Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE